These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 28198204)

  • 1. Nanomedicine applied to cardiovascular diseases: latest developments.
    Martín Giménez VM; Kassuha DE; Manucha W
    Ther Adv Cardiovasc Dis; 2017 Apr; 11(4):133-142. PubMed ID: 28198204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanospray Drying Technology: Existing Limitations and Future Challenges.
    Wui WT
    Recent Pat Drug Deliv Formul; 2015; 9(3):185-6. PubMed ID: 25966873
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular nanomedicine: the route ahead.
    Iafisco M; Alogna A; Miragoli M; Catalucci D
    Nanomedicine (Lond); 2019 Sep; 14(18):2391-2394. PubMed ID: 31456471
    [No Abstract]   [Full Text] [Related]  

  • 5. Nano-medicine and Vascular Endothelial Dysfunction: Options and Delivery Strategies.
    Taneja G; Sud A; Pendse N; Panigrahi B; Kumar A; Sharma AK
    Cardiovasc Toxicol; 2019 Feb; 19(1):1-12. PubMed ID: 30448914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and Therapeutic Nanoparticles in Cardiovascular Diseases.
    Tyler PD; Kang PM
    Curr Pharm Des; 2015; 21(42):6070-80. PubMed ID: 26503151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-polymer hybrid nanocarrier-mediated cancer therapeutics: current status and future directions.
    Garg NK; Tandel N; Jadon RS; Tyagi RK; Katare OP
    Drug Discov Today; 2018 Sep; 23(9):1610-1621. PubMed ID: 29857164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular nanomedicine: a posse ad esse.
    Godin B; Ferrari M
    Methodist Debakey Cardiovasc J; 2012 Jan; 8(1):2-5. PubMed ID: 22891103
    [No Abstract]   [Full Text] [Related]  

  • 9. Perspective and potential of oral lipid-based delivery to optimize pharmacological therapies against cardiovascular diseases.
    Rao S; Tan A; Thomas N; Prestidge CA
    J Control Release; 2014 Nov; 193():174-87. PubMed ID: 24852093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the Renin-Angiotensin-Aldosterone System and Its Pharmacological Inhibitors in Cardiovascular Diseases: Complex and Critical Issues.
    Borghi C; ; Rossi F;
    High Blood Press Cardiovasc Prev; 2015 Dec; 22(4):429-44. PubMed ID: 26403596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of nanotechnology approaches for cardiovascular disease: a personal perspective.
    Buxton DB
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(2):149-55. PubMed ID: 20049786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmaceutical technology problems in the preparation of drugs for the treatment of cardiovascular diseases].
    Moldenhauer H
    Pharmazie; 1979 Aug; 34(8):500-6. PubMed ID: 538075
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent Patents, Formulation and Characterization of Nanoliposomes.
    Rohilla S; Dureja H
    Recent Pat Drug Deliv Formul; 2015; 9(3):213-24. PubMed ID: 26118425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotherapeutic Solutions for Cardiovascular Disease.
    Cooke JP; Atkins J
    Methodist Debakey Cardiovasc J; 2016 Sep; 12(3):132-133. PubMed ID: 27826365
    [No Abstract]   [Full Text] [Related]  

  • 15. Nanomedicine and drug delivery.
    Wei C; Wei W; Morris M; Kondo E; Gorbounov M; Tomalia DA
    Med Clin North Am; 2007 Sep; 91(5):863-70. PubMed ID: 17826106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Emerging Role of Nanotechnology in Cell and Organ Transplantation.
    Tasciotti E; Cabrera FJ; Evangelopoulos M; Martinez JO; Thekkedath UR; Kloc M; Ghobrial RM; Li XC; Grattoni A; Ferrari M
    Transplantation; 2016 Aug; 100(8):1629-38. PubMed ID: 27257995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomaterial Based Approaches for the Diagnosis and Therapy of Cardiovascular Diseases.
    Sharma PA; Maheshwari R; Tekade M; Tekade RK
    Curr Pharm Des; 2015; 21(30):4465-78. PubMed ID: 26354926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Developments in Nanomaterials-Based Drug Delivery and Upgrading Treatment of Cardiovascular Diseases.
    Mohamed NA; Marei I; Crovella S; Abou-Saleh H
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress of researches on drug-loaded nanoparticles].
    Zhao J; Sheng Y; Shan X; Zhang X; Yuan Y; Liu C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Feb; 25(1):220-3. PubMed ID: 18435295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theranostic Applications of Nanomaterials in the Field of Cardiovascular Diseases.
    Sahoo RK; Singh H; Thakur K; Gupta U; Goyal AK
    Curr Pharm Des; 2022; 28(2):91-103. PubMed ID: 34218771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.